Newer technetium-99m--labeled myocardial perfusion imaging agents: clinical indications.
Bisson
G
G
Department of Nuclear Medicine, Hôtel-Dieu de Montréal, Québec, Canada.
Hendel
R C
RC
Taillefer
R
R
D003327:Coronary Disease / Q000000981:diagnostic imaging; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D015609:Organotechnetium Compounds / Q000493:pharmacokinetics; D010091:Oximes / Q000493:pharmacokinetics; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi / Q000493:pharmacokinetics
D015609:Organotechnetium Compounds; D010091:Oximes; D017256:Technetium Tc 99m Sestamibi; C060156:technetium Tc 99m teboroxime